Translating Human Retinal Pigment Epithelium Biology into Disease Treatments using Induced Pluripotent Stem Cells
Kapil Bharti, Ph.D.
Senior investigator and Chief
Ocular and Stem Cell Translational Research Section
National Eye Institute
Dr. Bharti will summarize his team’s development of a therapy for age-related macular degeneration (AMD), a leading cause of vision loss in people age 65 and older.